These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Efficacy and safety of endoscopic submucosal dissection for gastrointestinal neuroendocrine tumors: a 10-year data analysis of Northern China. Chen X, Li B, Wang S, Yang B, Zhu L, Ma S, Wu J, He Q, Zhao J, Zheng Z, Li S, Wang T, Liang L. Scand J Gastroenterol; 2019 Mar; 54(3):384-389. PubMed ID: 31037980 [Abstract] [Full Text] [Related]
5. Short- and long-term outcomes of endoscopic resection of rectal neuroendocrine tumours: analyses according to the WHO 2010 classification. Nakamura K, Osada M, Goto A, Iwasa T, Takahashi S, Takizawa N, Akahoshi K, Ochiai T, Nakamura N, Akiho H, Itaba S, Harada N, Iju M, Tanaka M, Kubo H, Somada S, Ihara E, Oda Y, Ito T, Takayanagi R. Scand J Gastroenterol; 2016 Mar; 51(4):448-55. PubMed ID: 26540372 [Abstract] [Full Text] [Related]
6. Endoscopic submucosal resection with an endoscopic variceal ligation device for the treatment of rectal neuroendocrine tumors. Ebi M, Nakagawa S, Yamaguchi Y, Tamura Y, Izawa S, Hijikata Y, Shimura T, Funaki Y, Ogasawara N, Sasaki M, Joh T, Kasugai K. Int J Colorectal Dis; 2018 Dec; 33(12):1703-1708. PubMed ID: 30167779 [Abstract] [Full Text] [Related]
7. Recurrence pattern and surveillance strategy for rectal neuroendocrine tumors after endoscopic resection. Chung HG, Goh MJ, Kim ER, Hong SN, Kim TJ, Chang DK, Kim YH. J Gastroenterol Hepatol; 2021 Apr; 36(4):968-973. PubMed ID: 32864790 [Abstract] [Full Text] [Related]
9. The Ki-67 labeling index and lymphatic/venous permeation predict the metastatic potential of rectal neuroendocrine tumors. Sugimoto S, Hotta K, Shimoda T, Imai K, Yamaguchi Y, Nakajima T, Oishi T, Mori K, Takizawa K, Kakushima N, Tanaka M, Kawata N, Matsubayashi H, Ono H. Surg Endosc; 2016 Oct; 30(10):4239-48. PubMed ID: 26718357 [Abstract] [Full Text] [Related]
10. [Clinicopathologic characteristics and prognosis of rectal neuroendocrine neoplasms]. Liu T, Liu P, Wu T, Pan Y, Chen G, Wang P, Jiang Y, Wu Y, Wang X. Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep 25; 20(9):1015-1019. PubMed ID: 28900992 [Abstract] [Full Text] [Related]
14. Clinical impact of endoscopic ultrasonography for small rectal neuroendocrine tumors. Kim JH, Moon W, Park SJ, Park MI, Kim SE, Ku KH, Lee GW, Choi YJ. Turk J Gastroenterol; 2014 Dec 25; 25(6):657-60. PubMed ID: 25599777 [Abstract] [Full Text] [Related]
15. Advantage of endoscopic mucosal resection with a cap for rectal neuroendocrine tumors. Park SB, Kim HW, Kang DH, Choi CW, Kim SJ, Nam HS. World J Gastroenterol; 2015 Aug 21; 21(31):9387-93. PubMed ID: 26309365 [Abstract] [Full Text] [Related]
17. Clinical outcomes of endoscopic mucosal resection for rectal neuroendocrine tumor. Kim J, Kim JH, Lee JY, Chun J, Im JP, Kim JS. BMC Gastroenterol; 2018 Jun 05; 18(1):77. PubMed ID: 29866049 [Abstract] [Full Text] [Related]
19. Long-term prognosis of an endoscopically treated rectal neuroendocrine tumor: 10-year experience in a single institution. Sung HY, Kim SW, Kang WK, Kim SY, Jung CK, Cho YK, Park JM, Lee IS, Choi MG, Chung IS. Eur J Gastroenterol Hepatol; 2012 Aug 05; 24(8):978-83. PubMed ID: 22647741 [Abstract] [Full Text] [Related]